Document is current
Any future updates will be listed below
-
Authors
Nakanishi-Koakutsu, Misato https://orcid.org/0000-0001-6205-6024
Miki, Kenji https://orcid.org/0000-0001-7901-6133
Naka, Yuki
Sasaki, Masako
Wakimizu, Takayuki
Napier, Stephanie C.
Okubo, Chikako https://orcid.org/0000-0001-5562-410X
Narita, Megumi https://orcid.org/0000-0002-8198-4042
Nishikawa, Misato
Hata, Reo
Chonabayashi, Kazuhisa
Hotta, Akitsu https://orcid.org/0000-0002-2619-7441
Imahashi, Kenichi
Nishimoto, Tomoyuki
Yoshida, Yoshinori https://orcid.org/0000-0001-5511-9090
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP17H04176, JP 21H02912, JP19K16041, JP18K15120, JP18KK0461)
Fondation Leducq (18CVD05)
Japan Agency for Medical Research and Development (JP20bm0104001, JP21bm0204003, JP21bm0804008, JP21bm0804022, JP23bm1423011, JP23bm132300, JP21mk0101189, JP22mk0101241, JP22ym0126091, JP21bk0104095)
- License Information
-
More Information
Article History
Received: 3 September 2022
Accepted: 11 January 2024
First Online: 28 February 2024
Competing interests
: The authors declare the following competing interests: Y.Y. is a scientific advisor of Orizuru Therapeutics, Inc. and received research funding from Takeda Pharmaceutical Company, Ltd. and Altos Labs, Inc. S.C.N. and K.I. are employees of Takeda Pharmaceutical Company, Ltd. T.N. is an employee of Orizuru Therapeutics, Inc. M.N.K, K.M., and Y.Y. are the inventors of the patent application (WO2021/033699 and 2022/125789). The other authors declare no competing interests.
